Cargando…

Cyclin D activates the Rb tumor suppressor by mono-phosphorylation

The widely accepted model of G(1) cell cycle progression proposes that cyclin D:Cdk4/6 inactivates the Rb tumor suppressor during early G(1) phase by progressive multi-phosphorylation, termed hypo-phosphorylation, to release E2F transcription factors. However, this model remains unproven biochemical...

Descripción completa

Detalles Bibliográficos
Autores principales: Narasimha, Anil M, Kaulich, Manuel, Shapiro, Gary S, Choi, Yoon J, Sicinski, Piotr, Dowdy, Steven F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076869/
https://www.ncbi.nlm.nih.gov/pubmed/24876129
http://dx.doi.org/10.7554/eLife.02872
Descripción
Sumario:The widely accepted model of G(1) cell cycle progression proposes that cyclin D:Cdk4/6 inactivates the Rb tumor suppressor during early G(1) phase by progressive multi-phosphorylation, termed hypo-phosphorylation, to release E2F transcription factors. However, this model remains unproven biochemically and the biologically active form(s) of Rb remains unknown. In this study, we find that Rb is exclusively mono-phosphorylated in early G(1) phase by cyclin D:Cdk4/6. Mono-phosphorylated Rb is composed of 14 independent isoforms that are all targeted by the E1a oncoprotein, but show preferential E2F binding patterns. At the late G(1) Restriction Point, cyclin E:Cdk2 inactivates Rb by quantum hyper-phosphorylation. Cells undergoing a DNA damage response activate cyclin D:Cdk4/6 to generate mono-phosphorylated Rb that regulates global transcription, whereas cells undergoing differentiation utilize un-phosphorylated Rb. These observations fundamentally change our understanding of G(1) cell cycle progression and show that mono-phosphorylated Rb, generated by cyclin D:Cdk4/6, is the only Rb isoform in early G(1) phase. DOI: http://dx.doi.org/10.7554/eLife.02872.001